Cardinal Health Purchases The Harvard Drug Group For $1.115 Billion
June 05, 2015 at 08:17 AM EDT
Cardinal Health Inc (NYSE: CAH) has agreed to purchase The Harvard Drug Group, a privately held generics company, in a deal valued at ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.